Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
927.2 DKK | -0.02% | +0.84% | +32.85% |
01:55pm | Structure Therapeutics' obesity drug meets main goal in mid-stage study | RE |
12:08pm | JPMorgan European G&I raises dividend after outperforming benchmark | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.85% | 598B | |
+42.15% | 739B | |
-5.24% | 353B | |
+17.81% | 318B | |
+5.09% | 285B | |
+16.55% | 240B | |
+9.46% | 210B | |
-5.36% | 206B | |
+7.78% | 164B | |
+1.98% | 162B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Most Patients Discontinue Weight-Loss Drugs in US Before Health Benefits Show, Report Says